Non-peptide

Low-Dose Naltrexone

Also known as

LDN · naltrexone low dose

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	LDN is naltrexone at lower amounts, an oral opioid-receptor-blocking medicine discussed off label for chronic pain, fatigue and brain fog; it is not a peptide.
What people seek	Less symptom burden, such as easier daily activity or clearer conversation. The debated endorphin-rebound explanation is not verified by feeling better or worse.

Notes

Low-dose naltrexone (LDN) is an oral medicine discussed for chronic pain, fatigue and brain fog, especially in chronic-illness communities. Reports range from easier daily activity and clearer thinking to worse sleep, more fatigue or no lasting benefit. It blocks opioid receptors, so opioid interactions matter even when the amount sounds small.

Low-dose naltrexone (LDN) is an opioid-receptor-blocking medicine used off label for conditions such as chronic pain; it is the same substance as the LDN entry.

The same medicine at a lower amount. LDN is a name for low-dose naltrexone, not a separate peptide. People describe swallowed tablets, compounded capsules and oral liquid preparations. Those accounts do not establish equivalent injected or nasal use. My experience with low dose Naltrexone (Community discussion · Accessed 2026-09-30)

The goal is less symptom burden. Pain, exhausting fatigue, poor concentration and unrefreshing sleep drive much of the discussion. An easier shower or clearer conversation may matter more than a noticeable energy rush. Autoimmune and gut-health stories do not prove correction of the underlying illness. Stories of LDN helping with fatigue (Community discussion · Accessed 2026-09-30) · My experience with low dose Naltrexone (Community discussion · Accessed 2026-09-30)

The endorphin-rebound idea remains debated. Community explanations propose that temporary opioid-receptor blocking is followed by increased activity of the body's natural pain-relieving chemicals. Contributors dispute the timing and supporting evidence; feeling better or worse does not verify that mechanism. Rebound effect (Community discussion · Accessed 2026-09-30)

Source context — My experience with low dose Naltrexone: Deleted user identity. Prescription medicines changed concurrently. Canada approval claims and mechanism explanations were not adopted. 12–25 mg reports do not become the ordinary LDN band; dilution recipe excluded.

Source context — Stories of LDN helping with fatigue: Positive-experience prompt invites selection bias. Low-Blueberry8948 also appears in the brain-fog thread and is not an independent corroborating account. Some nested replies remain collapsed.

Source context — Rebound effect: Forum explanation is not a low-dose measurement. The quoted 72–108-hour receptor study concerns conventional-dose naltrexone and was not freshly inspected; its quoted value is not adopted as LDN half-life.

What people notice

Pain and usable energy	Some report less burning nerve/joint pain or more capacity for ordinary tasks. Another reports milder post-activity crashes without more overall energy.
Thinking and mood	Reports include easier speech, work and less anxiety, but also worse brain fog after changing the amount.
No lasting benefit	A detailed diary ended with no net benefit despite early good days; another user reports no fatigue improvement after five months at 4.5 mg.

Notes

Less pain and more usable energy. Reports include less burning nerve or joint pain and enough capacity for laundry or leaving home. Another contributor described less severe post-activity crashes without greater overall energy; these are different outcomes. Stories of LDN helping with fatigue (Community discussion · Accessed 2026-09-30)

Clearer thinking and steadier mood. People describe finishing sentences, working more easily and less anxiety. Others report increased fog after an amount change. A benefit for one symptom does not mean pain, sleep and fatigue improve together. Stories of LDN helping with fatigue (Community discussion · Accessed 2026-09-30) · Any success stories for brain fog? (Community discussion · Accessed 2026-09-30)

An encouraging diary ended without net benefit. Smart-Pen203's early better days and later disappointment belong to one story. Illness, sugar/gluten changes, exercise and other care shifted too. Its eventual nonresponse should remain beside favorable accounts. My LDN Journal (Personal report · Accessed 2026-09-30)

Dramatic improvement and nonresponse coexist. The Biohackers author reports better mood, sleep, gut symptoms and stamina, while also changing several prescription medicines. A separate commenter reports no chronic-fatigue improvement after five months at 4.5 mg. Medication changes and multi-agent use complicate attribution. My experience with low dose Naltrexone (Community discussion · Accessed 2026-09-30)

Source context — Any success stories for brain fog?: Self-selected reports cannot establish success rates, tolerance or causes. Proposed 6 mg increase was not an observed outcome.

Source context — My LDN Journal: One changing-dose longitudinal account, not many independent users. Infection, activity, diet and other care changed; product unverified. Tom-Tortuga's route/form is unstated.

Doses people talk about

1.5–4.5 mg oral daily	Repeated in the accounts. One night-time diary used 1.5, 2, 2.5, 3 and 4.5 mg before reducing; that history is not a recommended progression or target.
Smaller or divided amounts	A sleep-thread user describes 0.1–0.5 mg. A separate fatigue account uses 5 mg total daily split between morning and about 6 pm, with portion sizes unstated.
Higher separate experiments	One author describes 3–25 mg experiments, later 3 mg/day at bedtime, and fatigue improvement at 12 mg. Those larger amounts are separate from the repeated 1.5–4.5 mg picture.

Notes

Oral: 1.5–4.5 mg once daily appears repeatedly. The long diary used 1.5, 2, 2.5, 3 and 4.5 mg at night before reducing. These were amounts per administration and daily totals in that account, not a recommended progression or proof that 4.5 mg is a target. My LDN Journal (Personal report · Accessed 2026-09-30)

Smaller amounts and split daily totals also appear. A sleep-thread contributor describes 0.1–0.5 mg. A different fatigue-thread user reports 5 mg total per day divided between morning and about 6 pm; the individual portions are unstated. That is not 5 mg twice daily. Insomnia after 1.5 mg (Community discussion · Accessed 2026-09-30) · Stories of LDN helping with fatigue (Community discussion · Accessed 2026-09-30)

Higher experiments are a separate history. The Biohackers author described 3–25 mg experiments, later 3 mg/day at bedtime, and fatigue improvement at 12 mg. Those larger amounts should not be folded into the 1.5–4.5 mg discussion or assumed more effective. My experience with low dose Naltrexone (Community discussion · Accessed 2026-09-30)

Source context — Insomnia after 1.5 mg: Short uncontrolled histories; planned increase was not completed in the post. No objective sleep measures or final outcome; do not turn replies' advice into recommendations.

Half-life, onset & duration

Felt onset	Reports range from almost immediate energy at 0.5 mg to fatigue change within two weeks and pain change after 7–8 weeks. Early better days can reverse.
Felt duration	No dependable single-dose benefit window. One account describes insomnia into the night even after morning use; that does not measure clearance.
Half-life	The conventional oral-tablet label gives about 4 hours for naltrexone and 13 for its breakdown product. These are not dedicated low-dose measurements or an opioid-safe interval.
Blood peak	Within one hour in conventional oral-tablet labeling; this does not establish low-dose benefit onset.

Notes

Same-day changes and slower benefits both occur. One contributor felt more energy almost immediately at 0.5 mg. Another reported fatigue improvement within two weeks but pain improvement after seven to eight weeks. These are separate symptom timelines, not a usual onset. Stories of LDN helping with fatigue (Community discussion · Accessed 2026-09-30)

Early improvement can reverse. The diary reported a notably better day five after rough first days, but its final assessment was no net benefit. First-night insomnia or an encouraging day does not predict the eventual outcome. My LDN Journal (Personal report · Accessed 2026-09-30)

No dependable single-dose benefit window. The reports do not establish a standard number of hours of pain relief or clearer thinking. The Biohackers author describes joint pain about fifteen minutes after dosing, lasting about twenty minutes; that is an adverse episode, not benefit duration. My experience with low dose Naltrexone (Community discussion · Accessed 2026-09-30)

Sleep disruption can outlast the hoped-for boost. The Phoenix Rising author described extra mental energy with insomnia into the night even after morning use. That rapidly changing experiment does not measure how long the medicine stays in the body. Low Dose Naltrexone Experimentation (Community discussion · Accessed 2026-09-30)

About four hours is a repeated blood-half-life figure. Half-life means the time for the blood amount to fall by half. The rebound thread repeats conventional naltrexone information; its users did not measure a dedicated low-dose half-life. Rebound effect (Community discussion · Accessed 2026-09-30)

Four-hour blockade is a different, disputed claim. A reply describes four hours of blocking followed by twenty hours of rebound. The questioner asks for measurements, while the reply points to clinical experience. This proposed schedule is not a verified receptor clock or opioid-safe interval. Rebound effect (Community discussion · Accessed 2026-09-30)

Four hours for naltrexone; thirteen for its breakdown product. The conventional oral-tablet label gives these mean half-lives and a blood peak within one hour. They do not establish low-dose benefit timing. DailyMed: Naltrexone Hydrochloride 50 mg Tablets (Official context · Accessed 2026-09-30)

Source context — Low Dose Naltrexone Experimentation: Same author's cross-posted five-day notes are one account. Rapid amount changes and sleep medicines confound attribution; cardiac damage speculation and commenters' immune-adaptation explanations are not accepted.

Source context — DailyMed: Naltrexone Hydrochloride 50 mg Tablets: Approved conventional-dose oral-tablet label; 50–200 mg dose-proportional data are not dedicated LDN kinetics. Pregnancy/lactation wording is label-specific, not a full current evidence review.

Cycles people discuss

Consecutive use	Separate histories span twelve days, about six months and two-and-a-half years, with changing amounts. No standard weeks-on/weeks-off calendar emerges.
Long use and changing response	One 4.5 mg user reports benefit for roughly two years before it faded; a blogger reports fifteen years at 1.5 mg. Neither establishes scheduled breaks or long-term safety.

Notes

Consecutive use is more visible than fixed cycles. Histories include twelve days, about six months and two-and-a-half years. They involve different people and amount changes; none establishes a standard weeks-on/weeks-off calendar. Insomnia after 1.5 mg (Community discussion · Accessed 2026-09-30) · My LDN Journal (Personal report · Accessed 2026-09-30) · Any success stories for brain fog? (Community discussion · Accessed 2026-09-30)

Long use does not ensure a lasting response. One 4.5 mg user describes benefit for roughly two years, followed by declining effectiveness. A blogger reports fifteen years at 1.5 mg; both are personal histories rather than evidence for scheduled breaks or long-term safety. Any success stories for brain fog? (Community discussion · Accessed 2026-09-30) · The New ME Treatments I've Tried Over the Past Two Years (Personal report · Accessed 2026-09-30)

Source context — Any success stories for brain fog?: Self-selected reports cannot establish success rates, tolerance or causes. Proposed 6 mg increase was not an observed outcome.

Source context — The New ME Treatments I've Tried Over the Past Two Years: One medication-sensitive blogger's retrospective report. Fifteen-year use does not establish long-term safety; secondhand clinician reports at other amounts are not firsthand results.

Stacks

Diet, activity and medicines	Accounts include diet/exercise changes and other care; a dramatic improvement story also changes several prescription medicines. The records do not establish a specific beneficial combination.

Notes

Other changes in the diary: Sugar, gluten, exercise, illness and other care changed during the long account. Those factors complicate attribution to LDN. [community]

Watch for

Opioid interactions	Naltrexone can block opioid pain relief and trigger withdrawal in opioid-dependent people. Surgery and emergency pain care need an informed clinical team.
Sleep, gut and fatigue	Vivid dreams, nightmares, insomnia, nausea, stomach discomfort, headache, worse fatigue and palpitations appear in reports. Persistent worsening is not proof of immune improvement.
Pregnancy and organ disease	Label cautions cover pregnancy, breastfeeding, liver injury and kidney impairment; low amounts do not remove the need for individual assessment.
Pain benefit is uncertain	The 2026 INNOVA trial in 98 women with fibromyalgia found no clinically meaningful pain advantage over placebo at 4.5 mg/day. It does not answer every other condition.

Notes

Opioids require clinical review. Naltrexone can block opioid pain relief and precipitate withdrawal in opioid-dependent people. Surgery and emergency pain treatment need an informed care team. DailyMed: Naltrexone Hydrochloride 50 mg Tablets (Official context · Accessed 2026-09-30)

Sleep, gut and fatigue changes deserve attention. Reports include vivid dreams, nightmares, insomnia, nausea, stomach discomfort, headache and worse fatigue. Persistent worsening is not proof of beneficial immune adjustment; the Phoenix Rising author also reported palpitations. My LDN Journal (Personal report · Accessed 2026-09-30) · Insomnia after 1.5 mg (Community discussion · Accessed 2026-09-30) · Low Dose Naltrexone Experimentation (Community discussion · Accessed 2026-09-30)

Pregnancy and organ disease need specific assessment. The label cautions about pregnancy, breastfeeding, liver injury and kidney impairment. DailyMed: Naltrexone Hydrochloride 50 mg Tablets (Official context · Accessed 2026-09-30)

Fibromyalgia results remain uncertain. The 2026 INNOVA trial in 98 women found no clinically meaningful pain-related advantage over placebo with 4.5 mg/day across short- and long-term follow-up. That challenges broad pain-benefit claims without determining every other condition's response. INNOVA: 12-month randomized LDN trial in women with fibromyalgia (Official context · Accessed 2026-09-30)

Source context — INNOVA: 12-month randomized LDN trial in women with fibromyalgia: Abstract inspected, not full paper. 98 women with fibromyalgia, add-on 4.5 mg/day; does not answer every other condition or individual account.

Full notes

What LDN is and why people try it

The same medicine at a lower amount. LDN is a name for low-dose naltrexone, not a separate peptide. People describe swallowed tablets, compounded capsules and oral liquid preparations. Those accounts do not establish equivalent injected or nasal use. Reddit r/Biohackers Community
The goal is less symptom burden. Pain, exhausting fatigue, poor concentration and unrefreshing sleep drive much of the discussion. An easier shower or clearer conversation may matter more than a noticeable energy rush. Autoimmune and gut-health stories do not prove correction of the underlying illness. Reddit r/LowDoseNaltrexone Reddit r/Biohackers
The endorphin-rebound idea remains debated. Community explanations propose that temporary opioid-receptor blocking is followed by increased activity of the body's natural pain-relieving chemicals. Contributors dispute the timing and supporting evidence; feeling better or worse does not verify that mechanism. Reddit r/LowDoseNaltrexone

Benefits people report

Less pain and more usable energy. Reports include less burning nerve or joint pain and enough capacity for laundry or leaving home. Another contributor described less severe post-activity crashes without greater overall energy; these are different outcomes. Reddit r/LowDoseNaltrexone
Clearer thinking and steadier mood. People describe finishing sentences, working more easily and less anxiety. Others report increased fog after an amount change. A benefit for one symptom does not mean pain, sleep and fatigue improve together. Reddit r/LowDoseNaltrexone Reddit r/LowDoseNaltrexone
Fibromyalgia results remain uncertain. The 2026 INNOVA trial in 98 women found no clinically meaningful pain-related advantage over placebo with 4.5 mg/day across short- and long-term follow-up. That challenges broad pain-benefit claims without determining every other condition's response. Official context

Doses people discuss

Oral: 1.5–4.5 mg once daily appears repeatedly. The long diary used 1.5, 2, 2.5, 3 and 4.5 mg at night before reducing. These were amounts per administration and daily totals in that account, not a recommended progression or proof that 4.5 mg is a target. Personal report
Smaller amounts and split daily totals also appear. A sleep-thread contributor describes 0.1–0.5 mg. A different fatigue-thread user reports 5 mg total per day divided between morning and about 6 pm; the individual portions are unstated. That is not 5 mg twice daily. Reddit r/LowDoseNaltrexone Reddit r/LowDoseNaltrexone
Higher experiments are a separate history. The Biohackers author described 3–25 mg experiments, later 3 mg/day at bedtime, and fatigue improvement at 12 mg. Those larger amounts should not be folded into the 1.5–4.5 mg discussion or assumed more effective. Reddit r/Biohackers

Half-life discussed in the community

About four hours is a repeated blood-half-life figure. Half-life means the time for the blood amount to fall by half. The rebound thread repeats conventional naltrexone information; its users did not measure a dedicated low-dose half-life. Reddit r/LowDoseNaltrexone
Four-hour blockade is a different, disputed claim. A reply describes four hours of blocking followed by twenty hours of rebound. The questioner asks for measurements, while the reply points to clinical experience. This proposed schedule is not a verified receptor clock or opioid-safe interval. Reddit r/LowDoseNaltrexone

When people first notice changes

Same-day changes and slower benefits both occur. One contributor felt more energy almost immediately at 0.5 mg. Another reported fatigue improvement within two weeks but pain improvement after seven to eight weeks. These are separate symptom timelines, not a usual onset. Reddit r/LowDoseNaltrexone
Early improvement can reverse. The diary reported a notably better day five after rough first days, but its final assessment was no net benefit. First-night insomnia or an encouraging day does not predict the eventual outcome. Personal report

How long noticeable effects last

No dependable single-dose benefit window. The reports do not establish a standard number of hours of pain relief or clearer thinking. The Biohackers author describes joint pain about fifteen minutes after dosing, lasting about twenty minutes; that is an adverse episode, not benefit duration. Reddit r/Biohackers
Sleep disruption can outlast the hoped-for boost. The Phoenix Rising author described extra mental energy with insomnia into the night even after morning use. That rapidly changing experiment does not measure how long the medicine stays in the body. Phoenix Rising ME/CFS forum

Ongoing use, courses and breaks

Consecutive use is more visible than fixed cycles. Histories include twelve days, about six months and two-and-a-half years. They involve different people and amount changes; none establishes a standard weeks-on/weeks-off calendar. Reddit r/LowDoseNaltrexone Personal report Reddit r/LowDoseNaltrexone
Long use does not ensure a lasting response. One 4.5 mg user describes benefit for roughly two years, followed by declining effectiveness. A blogger reports fifteen years at 1.5 mg; both are personal histories rather than evidence for scheduled breaks or long-term safety. Reddit r/LowDoseNaltrexone Personal report

Good to know

Opioids require clinical review. Naltrexone can block opioid pain relief and precipitate withdrawal in opioid-dependent people. Surgery and emergency pain treatment need an informed care team. Official context
Sleep, gut and fatigue changes deserve attention. Reports include vivid dreams, nightmares, insomnia, nausea, stomach discomfort, headache and worse fatigue. Persistent worsening is not proof of beneficial immune adjustment; the Phoenix Rising author also reported palpitations. Personal report Reddit r/LowDoseNaltrexone Phoenix Rising ME/CFS forum
Pregnancy and organ disease need specific assessment. The label cautions about pregnancy, breastfeeding, liver injury and kidney impairment. Official context
Identity and long-term uncertainty remain. Unverified preparations may differ from their label; anecdotes do not establish their contents or long-term safety. Storage depends on the actual formulation. Severe allergy, chest pain, new neurological symptoms or uncontrolled blood pressure or glucose call for medical care. Community

Separately: oral-label timing

Four hours for naltrexone; thirteen for its breakdown product. The conventional oral-tablet label gives these mean half-lives and a blood peak within one hour. They do not establish low-dose benefit timing. Official context

From community discussion

Better sleep can become worse sleep. At 1.5 mg, DALTT moved dosing to night after fatigue, slept unusually well for several days, then developed nightmares and severe insomnia. Tom-Tortuga's separate 0.5 mg evening report involved one sleepless night and new limb/joint pain; route and form were unstated. Reddit r/LowDoseNaltrexone Personal report
An encouraging diary ended without net benefit. Smart-Pen203's early better days and later disappointment belong to one story. Illness, sugar/gluten changes, exercise and other care shifted too. Its eventual nonresponse should remain beside favorable accounts. Personal report
More made a longstanding user tired. The blogger became more tired on 3 mg after years at 1.5 mg; this eased on returning to 1.5 mg. That does not mean everyone needs less. Personal report
Dramatic improvement and nonresponse coexist. The Biohackers author reports better mood, sleep, gut symptoms and stamina, while also changing several prescription medicines. A separate commenter reports no chronic-fatigue improvement after five months at 4.5 mg. Medication changes and multi-agent use complicate attribution. Reddit r/Biohackers Community